Rachel J M Abbott

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 2

Top Topics

Randomized Controlled Trial

Genome Wide Analysis

Regulatory T Cells

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Dian Kortleve, Dora Hammerl, Mandy van Brakel, Rebecca Wijers, Daphne Roelofs, Kim Kroese, Mieke M Timmermans, Chen-Yi Liao, Shaozhuo Huang, Anita Trapman-Jansen, Renee Foekens, Justine Michaux, Monique T A de Beijer, Sonja I Buschow, Jeroen A A Demmers, Marleen Kok, Erik H J Danen, Michal Bassani-Sternberg, John W M Martens, Rachel J M Abbott, Reno Debets
TCR-engineered T-cells directed against Ropporin-1 constitute a safe and effective treatment for triple-negative breast cancer. Cancer discovery (2024)
Jonathan D Silk, Rachel J M Abbott, Katherine J Adams, Alan D Bennett, Sara Brett, Terri V Cornforth, Katherine L Crossland, David J Figueroa, Junping Jing, Caitriona O'Connor, Annette Pachnio, Lea Patasic, Carlos E Peredo, Adriano Quattrini, Laura L Quinn, Alistair G Rust, Manoj Saini, Joseph P Sanderson, Dylan Steiner, Barbara Tavano, Preetha Viswanathan, Guy E Wiedermann, Ryan Wong, Bent K Jakobsen, Cedrik M Britten, Andrew B Gerry, Joanna E Brewer
Engineering Cancer Antigen-Specific T Cells to Overcome the Immunosuppressive Effects of TGF-β. Journal of immunology (Baltimore, Md. : 1950) (2021)